Effects of abciximab, ticlopidine, and combined abciximab/ticlopidine therapy on platelet and leukocyte function in patients undergoing coronary angioplasty Academic Article uri icon

Overview

MeSH Major

  • Angioplasty, Balloon, Coronary
  • Antibodies, Monoclonal
  • Anticoagulants
  • Blood Platelets
  • Immunoglobulin Fab Fragments
  • Leukocytes
  • Thrombosis
  • Ticlopidine

abstract

  • Combined therapy with abciximab and ticlopidine has a prolonged inhibitory effect on mural thrombosis formation relative to either treatment alone. Further, we demonstrated an unexpected effect of abciximab in enhancing P-selectin-mediated leukocyte adhesion.

publication date

  • March 14, 2000

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 10715258

Additional Document Info

start page

  • 1122

end page

  • 9

volume

  • 101

number

  • 10